# Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA

> **NCT07681752** · — · NOT_YET_RECRUITING · sponsor: **Institute of Tropical Medicine, Belgium** · enrollment: 150 (estimated)

## Conditions studied

- Ebola Hemorrhagic Fever
- Lassa Hemorrhagic Fever

## Interventions

- **DIAGNOSTIC_TEST:** FORTIFIEDx and DECIPHER bioassays

## Key facts

- **NCT ID:** NCT07681752
- **Lead sponsor:** Institute of Tropical Medicine, Belgium
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-07-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681752, "Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07681752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*